Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

Cleave Biosciences Raises $37M Series B

by posted 2years ago 3340 views
 The financing included the participation of new investors Celgene, Nextech Invest Ltd. and Arcus Ventures. Also participating in the round were Cleave's existing investors 5AM Ventures, Clarus Ventures, New Enterprise Associates (NEA), Orbimed Advisors, U.S. Venture Partners, Astellas Venture Management and Osage University Partners.